L-Ascorbic acid,compounds,mixt. with [R-(R*,R*)]-2,2-dichloro-N-[2-hydroxy-1- (hydroxymethyl)-2-(4-nitrophenyl)ethyl]- acetamide and [4S-(4R,4aR,5aR,6â,12aR)]-4- (dimethylamino)-1,4,4a,5,5a,6,11,12aoctahydro- 3,6,10,12,12a-pentahydroxy-6- methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride (39372-22-0)

Other Product

• 2-Naphthacenecarboxamide,4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-,monohydrochloride,(4S,4aR,5S,5aR,6S,12aS)-,mixt. with (1R,2R)-2,2-dichloro-N-[2- hydroxy-1-(hydroxymethyl)-2-(4-nitrophenyl)- ethyl]acetamide
• L-Ascorbic acid,compounds,mixt. with 3-[(4-amino-2-methyl-5-pyrimidinyl)- methyl]-5-(2-hydroxyethyl)-4-methylthiazolium chloride,(4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-2- naphthacenecarboxamide and riboflavin
• Sulfuric acid copper(2+) salt (1:1),compounds,mixt. with (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-2- naphthacenecarboxamide
• Estra-1,3,5(10)-triene-3,17-diol (17â)-,esters,3-benzoate,mixt. with 2-(diethylamino)-N-(2,6-dimethylphenyl)- acetamide monohydrochloride and (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-2- naphthacenecarboxamide monohydrochloride
• 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, [4S-(4α,4aα,5α,5aα,6β,12aα)]-
• l-Proline, 5-oxo-, compd. with [4S-(4α,4aα,5aα,6β,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide (1:1)
• Sulfuric acid copper(2+) salt (1:1),compounds,mixt. with [R-(R*,R*)]-2,2-dichloro-N-[2-hydroxy-1- (hydroxymethyl)-2-(4-nitrophenyl)ethyl]- acetamide
• L-Ascorbic acid,compounds,mixt. with 3-[[6-O-(6-deoxy-R-L-mannopyranosyl)-â- D-glucopyranosyl]oxy]-2-(3,4-dihydroxyphenyl)- 5,7-dihydroxy-4H-1-benzopyran-4- one,1-[4-[[4-O-(6-deoxy-R-Lmannopyranosyl)- â-D-glucopyranosyl]oxy]-2,- 6-dimethoxyphenyl]-3-(3,4-dimethoxyphenyl)- 2-propen-1-one,6-(â-D-glucopyranosyloxy)-7-hydroxy-2H-1- benzopyran-2-one and vitamin K
• Sulfamic acid, cyclohexyl-, compd. with [4S-(4α,4aα,5aα,6β,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide (1:1)
• 2,4-Hexadienoic acid, (E,E)-, compd. with [4S-(4α,4aα,5aα,6β,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide (1:1)
• Sulfuric acid, monododecyl ester, compd. with [4S-(4α,4aα,5aα,6β,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide (1:1)
• l-Proline, 5-oxo-, compd. with [4S-(4α,4aα,5α,5aα,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-2-naphthacenecarboxamide (1:1)
• Benzoic acid, 2-hydroxy-5-sulfo-, compd. with [4S-(4α,4aα,5α,5aα,6α,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide
• Sulfamic acid, hexyl-, compd. with [4S-(4α,4aα,5α,5aα,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-2-naphthacenecarboxamide (1:1)
• Sulfuric acid, monododecyl ester, compd. with [4S-(4α,4aα,5α,5aα,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methylene-1,11-dioxo-2-naphthacenecarboxamide (1:1)
• (4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide,phosphoric acid
• 2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,calcium salt (1:2), (4S,4aR,5S,5aR,6R,12aS)-
• 2-Naphthacenecarboxamide,4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-,hydrate (1:1), (4S,4aR,5S,5aR,6R,12aS)-
• Metaphosphoric acid (HPO3), compd. with [4S-(4α,4aα,5α,5aα,6α,12aα)]-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide (4:3), monosodium salt
• Oleandomycin,mixt. with (4S,4aR,5S,5aR,6S,12aS)-4-(dimethylamino)- 1,4,4a,5,5a,6,11,12a-octahydro-3,5,6,10,12,12ahexahydroxy- 6-methyl-1,11-dioxo-2- naphthacenecarboxamide,neomycin sulfate (salt) and (11â)-11,17,21-trihydroxypregna-1,4- diene-3,20-dione